Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs MRNA✓SelectedUSD · MRNASTX vs MRNA performance historyLatest closeAs of+2.28%11/18
Stock and ETF performance explorer

STX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-30.3%
MRNA return
+293.7%
Excess return
-324.0%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.3%-4.8%+7.1%+2.2%
7D-6.5%-20.9%+14.4%-7.0%
30D-21.9%-13.3%-8.7%-22.1%
3M-42.9%+212.6%-255.4%-37.5%
6M-30.3%+309.0%-339.3%-32.0%
All-30.3%+293.7%-324.0%-32.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling